Amundi Asset Management US’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$272M Buy
756,900
+31,621
+4% +$10.2M 0.21% 110
2020
Q4
$233M Buy
725,279
+167,364
+30% +$51.4M 0.2% 110
2020
Q3
$150M Sell
557,915
-114,101
-17% -$30.7M 0.16% 137
2020
Q2
$177M Buy
672,016
+118,618
+21% +$31.6M 0.21% 101
2020
Q1
$125M Buy
553,398
+264,692
+92% +$72.1M 0.22% 93
2019
Q4
$87.2M Buy
288,706
+48,764
+20% +$13.4M 0.1% 201
2019
Q3
$57.6M Sell
239,942
-6,561
-3% -$1.8M 0.09% 247
2019
Q2
$69.6M Sell
246,503
-116,363
-32% -$31.8M 0.06% 249
2019
Q1
$104M Buy
362,866
+25,247
+7% +$7.3M 0.15% 149
2018
Q4
$88.7K Sell
337,619
-3,899
-1% -$1.07M 0.08% 170
2018
Q3
$93.6M Buy
341,518
+80,889
+31% +$21M 0.12% 178
2018
Q2
$62M Buy
260,629
+5,906
+2% +$1.37M 0.09% 234
2018
Q1
$56M Buy
254,723
+35,662
+16% +$8.38M 0.09% 235
2017
Q4
$49.3M Buy
219,061
+201,168
+1,124% +$42.8M 0.08% 248
2017
Q3
$3.4M Sell
17,893
-9,388
-34% -$1.79M 0.01% 420
2017
Q2
$5.13M Buy
+27,281
New +$4.9M 0.02% 396

Other funds holding ELV

Amundi Asset Management US's ELV Position: Q1 2021 in Review

Amundi Asset Management US increased its Elevance Health (ELV) stake by 4.4% in Q1 2021, buying an estimated $10.2M and bringing the position to 756,900 shares worth $272M. The position accounts for 0.21% of the portfolio, ranked #110.

Amundi Asset Management US first reported a position in ELV in Q2 2017 and has held it in 16 quarters since. 1,212 funds tracked by Wall St. Rank hold ELV as of Q1 2021.

  • Amundi Asset Management US held 756,900 shares of Elevance Health worth $272M as of Q1 2021.
  • Amundi Asset Management US bought 31,621 Elevance Health shares in Q1 2021, an estimated $10.2M.
  • Elevance Health made up 0.21% of Amundi Asset Management US's portfolio in Q1 2021, its #110 holding.
  • Amundi Asset Management US first reported a position in Elevance Health in Q2 2017 and has held it in 16 quarters since.
  • 1,212 funds tracked by Wall St. Rank held Elevance Health as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.